You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Donor screening tests for HIV, HCV, and HBV from 2000 to 2010

From: Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010

  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
HIV            
   anti-HIV (EIA) DA* DA DA GC GC LG/GC LG/GC LG/BioRad LG/BioRad LG LG
   HIV-NAT      Roche/Chiron Roche/Chiron Roche/Chiron Roche/Chiron Roche/Chiron Roche/Chiron
HCV            
   anti-HCV (EIA) LG/SI§ LG/SI LG/SI LG LG/DA SI/LG LG LG LG LG LG
   HCV-NAT      Roche/Chiron Roche/Chiron Roche/Chiron Roche/Chiron Roche/Chiron Roche/Chiron
HBV            
   HBsAg (EIA/CLIA) DA/GC DA/GC DA/GC GC/DA GC GC/LG BioRad/SI Abbott Abbott Abbott Abbott
  1. *DA, Dong-A Pharm.
  2. GC, Green Cross co.
  3. LG, LG Corp.
  4. §SI, Samil co. LTD.